SIRT1 and metabolic disease: Obviously, further studies testing whether SIRT1 could work as a potential target for the therapeutic approaches of metabolic disorders, or could help monitor the effect of novel medications to ameliorate the clinical conditions of patients affected by AN, are needed with longitudinal design.